Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged Post author: Post published: May 3, 2024 Post category:uncategorized Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs). You Might Also Like Opioid δ-receptor agonists show promise for treating IBS-like symptoms February 7, 2025 High blood sugar impairs brain health even without diabetes December 3, 2024 Irregular sleep patterns lead to increased risk of type 2 diabetes, study finds July 18, 2024